XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Information about Incentive Plan

The following table contains information about the 2019 Plan as of December 31, 2022:

 

  Awards          Awards 
  Reserved for   Awards   Awards   Available for 
  Issuance   Issued   Exercised   Grant 
2019 Plan(1)   571,429    564,246    7,183    - 
Awards issued in excess of 2019 Plan   -    45,441    -    - 
Total   571,429    609,687    7,183    - 

 

(1)includes incentive stock options and restricted stock units discussed below.

Schedule of Incentive Stock Option Activity

The following table summarizes the Company’s incentive stock option activity and related information for the years ended December 31, 2022 and 2021.

 

        Weighted 
     Weighted   Average 
     Average   Contractual 
  Number of   Exercise   Term in 
   Options   Price   Years 
Outstanding at January 1, 2021   387,318   $1,124418    9.32 
Granted   90,478    3.960526    10.00 
Exercised   (7,183)   1.75     
Forfeited            
Cancelled   (28,571)   1.40     
Expired   (7,103)   1.75     
Outstanding at December 31, 2021   434,939   $1.678955    8.56 
            
Granted   195,000   $3.3461538    10.00 
Exercised   —-         
Forfeited            
Cancelled   (100,001)   1.40000     
Expired   (5,001)   1.40000     
Outstanding at December 31, 2022   524,937   $2.351416    8.38 
Exercisable at December 31, 2022   379,937   $1.777020    7.86 

Schedule of Assumptions used in Share-based Compensation

 

 

    2022    2021  
Volatility   277.84%     171.12%-183.48 %
Risk-free interest rate   4.06%     0.46% - 0.86 %
Dividend yield   0.0%     0.0 %
Expected term   5.0 years      5.0-5.75 years  

Schedule of Restricted Stock Units Grant

 

     Weighted 
     Average 
  Number of   Grant Date 
  Units   Fair Value 
Outstanding at December 31, 2020   39,524   $2.10 
Granted        
Exercised and converted to common shares   (39,524)   2.10 
Forfeited        
Outstanding at December 31, 2021        
Granted   96,114    1.61 
Exercised and converted to common shares   (5,682)   4.40 
Forfeited        
Outstanding at December 31, 2022   90,432   $1.43 
Exercisable at December 31, 2022   5,682   $4.40 

Summary of Common Stock Warrants

The following table shows a summary of common stock warrants for the years ended December 31, 2022 and 2021.

 

     Weighted   Weighted 
     Average   Average 
  Number of   Exercise   Contractual 
  Warrants   Price   Term in Years 
Outstanding at December 31, 2020   210,500   $0.85938    2.54 
            
Granted   3,426,690   $5.42717    4.98 
Exercised            
Forfeited            
Cancelled            
Expired            
Outstanding at December 31, 2021   3,637,190   $5.16281    4.63 
Granted            
Exercised            
Forfeited            
Cancelled            
Expired            
Outstanding at December 31, 2022   3,637,190   $5.16281    3.65 
Exercisable at December 31, 2022   3,637,190   $5.16281    3.65